Cargando…
Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice
Severe pre-eclampsia and eclampsia are rare but serious complications of pregnancy that threaten the lives of mothers during childbirth. Evidence supports the use of magnesium sulfate (MgSO4) as the first line treatment option for severe pre-eclampsia and eclampsia. Eclampsia is the third major caus...
Autores principales: | Bigdeli, Maryam, Zafar, Shamsa, Assad, Hafeez, Ghaffar, Adbul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608621/ https://www.ncbi.nlm.nih.gov/pubmed/23555626 http://dx.doi.org/10.1371/journal.pone.0059158 |
Ejemplares similares
-
Dynamics of evidence-informed health policy making in Pakistan
por: Haq, Zaeem, et al.
Publicado: (2017) -
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
por: Smith, Jeffrey Michael, et al.
Publicado: (2013) -
Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021)